Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009;114(4):221-7.
doi: 10.3109/03009730903225537.

Serum ADMA concentration-- an independent factor determining FMD impairment in cardiac syndrome X

Maciej Haberka  1 , Katarzyna Mizia-Stec, Zbigniew Gasior, Magdalena Mizia, Joanna Janowska, Michał Holecki, Barbara Zahorska-Markiewicz
Affiliations

Serum ADMA concentration-- an independent factor determining FMD impairment in cardiac syndrome X

Maciej Haberka et al. Ups J Med Sci. 2009.

Abstract

Mechanisms of decreased endogenous vascular reactivity in individuals with cardiac syndrome X (CSX) are not fully understood.

Aim: To evaluate the following serum markers: total nitric oxide (NO), asymmetric dimethylarginine (ADMA), platelet-derived growth factor (PDGF), and to establish their relation to ultrasound indexes of endothelial function and structural remodeling in CSX patients.

Method: The study group consisted of 43 CSX patients (mean age: 56.3 +/- 9 years), while the control group included 21 healthy subjects (mean age: 54.86 +/- 6.9 years). The high-resolution ultrasound was performed to measure: flow-mediated vasodilatation (FMD), nitroglycerine-mediated vasodilatation (NMD) and intima-media thickness (IMT) of carotid arteries.

Results: In CSX patients, significantly lower FMD (9.06 +/- 3.2%) and significantly higher IMT (0.667 +/- 0.14 mm) values were observed compared to healthy individuals (17.42 +/- 8.4%, 0.571 +/- 0.2 mm; P < 0.05). Mean total NO serum concentration was significantly higher in the CSX group (48.2 +/- 18.2 micromol/L) as compared to controls (32.1 +/- 1.4 micromol/L; P < 0.0001). There were no differences in serum ADMA and PDGF levels. In CSX patients, FMD values correlated with NO (r = 0.323; P = 0.039) and ADMA (r = -0.387; P = 0.012) serum levels; however, there were no significant correlations between NO and ADMA concentrations.

Conclusion: Serum ADMA concentration is the only independent factor determining FMD impairment.

PubMed Disclaimer

References

    1. Kaski JC. Pathophysiology and management of patients with chest pain and normal coronary arteriograms. Circulation. 2004;109:568–72. - PubMed
    1. Egashira K, Inou T, Hirooka Y, Yamada A, Urabe Y, Takeshita A. Evidence of impaired endothelium-dependent coronary vasodilatation in patients with angina pectoris and normal coronary angiograms. N Engl J Med. 1993;328:1659–64. - PubMed
    1. Masci PG, Laclaustra M, Lara JG, Kaski JC. Brachial artery flow-mediated dilatation and myocardial perfusion in patients with cardiac syndrome X. Am J Cardiol. 2005;95:1478–80. - PubMed
    1. Hurst T, Olson TH, Olson LE, Appleton CP. Cardiac syndrome X and endothelial dysfunction: new concepts in prognosis and treatment. Am J Med. 2006;119:560–6. - PubMed
    1. Corretti MC, Anderson TJ, Benjamin EJ, Celermajer D, Charbonneau F, Creager MA, et al. Guidelines for the ultrasound assessment of endothelial-dependent flow mediated vasodilatation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol. 2002;39:257–65. - PubMed

MeSH terms

LinkOut - more resources